Background & Aims-Immune responses in the intestine are controlled by regulatory T cells (Treg cells), which prevent inflammation in response to commensal bacteria. A specific population of intestinal dendritic cells (DCs), marked by expression of CD103, generate Tregs more efficiently than other DC populations, through mechanisms that involve retinoic acid and transforming growth factor (TGF)-β. However, it is not clear how CD103 + DCs are specialized for this function. We investigated the ability of CD103 + DCs to promote Treg generation through activation of TGF-β and the role of integrins with the αv subunit in this process.
Introduction
In the gastrointestional tract, the immune system must protect against potential pathogens whilst preventing destructive inflammatory responses to the host's commensal microbiota 1 . This is achieved in part through a complex and active network of specialized immune cells and regulatory cytokines 2 . Breakdown of this dynamic balance between immune response and regulation is considered a major contributor to Inflammatory Bowel Disease (IBD) 3 .
Regulatory T cells (Tregs), characterized by expression of the forkhead transcription factor FoxP3, are an important component of intestinal immune regulation and loss of Tregs causes spontaneous colitis, driven by microbial products in the gut 4 . A major population of FoxP3 + Tregs develop from self-reactive cells in the thymus and these 'naturally occurring' nTregs appear to regulate autoimmunity 5 . FoxP3 + expression can also be stimulated in naïve T cells in the periphery, providing an additional source of Tregs 6, 7 with a different potential antigen repertoire to nTregs. Development of these 'adaptive' or induced Tregs (iTregs) requires low levels of antigen and costimulation, combined with the immunoregulatory cytokine TGF-β 8, 9 . The generation of iTregs may be of particular importance in mucosal tissues such as the intestine, as it provides a mechanism by which tolerance can be induced against dietary antigens and the commensal microflora 4 .
Recently, a specific population of dendritic cells (DCs) from the mouse intestinal lamina propria and MLNs, marked by surface expression of αE integrin chain (CD103), were implicated in the generation of iTregs 10, 11 .. In co-culture with naïve CD4 + T cells, CD103 + DCs produced more FoxP3 + Tregs than their CD103 − counterparts 10, 11 . The induction of Tregs by these DCs could be prevented by neutralization of TGF-β and retinoic acid (RA); conversely addition of exogenous TGF-β and/or RA promoted Treg generation to similar levels in both CD103 + and CD103 − DCs. Therefore the preferential induction of FoxP3 + Tregs by CD103 + DCs was due to promotion of TGF-β and RA signaling to T cells. It has been shown that CD103 + DCs produce high levels of RA which in turn stabilizes TGF-β-induced FoxP3 expression in T cells whilst inhibiting Th17 differentiation. However, little is known of the contribution of CD103 + DCs to TGF-β production, despite the requirement for TGF-β for the effects of RA. We therefore set out to determine whether CD103 + DCs were also specialized for promoting TGF-β signaling.
Here we present evidence that enhanced generation of FoxP3 + Tregs by CD103 + DCs is also due to their ability to activate latent TGF-β. Thus, MLN CD103 + DCs generate higher numbers of Tregs than CD103 − DCs when cultured in the presence of latent, but not active TGF-β. This is dependent on DC expression of αv integrins in vitro and in vivo, and mice lacking αv in the immune system are unable to generate intestinal Tregs from naïve T cells in response to oral antigen. Furthermore, MLN CD103 + DCs alone express the αvβ8 integrin heterodimer. Hence these data show that the expression of αv integrins by intestinal DCs is critical for the generation of FoxP3 + Tregs in response to intestinal antigens, and that the CD103 + subset of DCs are uniquely specialized for this function through the expression of αvβ8 allowing activation of latent TGF-β.
Results and Discussion

CD103 + MLN DCs activate latent TGF-β to generate FoxP3 + Tregs
In agreement with previous studies 10, 11 , we found that CD103 + DCs from mouse MLNs generated on average twice as many FoxP3 + T cells in in vitro co-culture than their CD103 − counterparts ( Figure 1A ). This was dependent on TGF-β as TGF-β blocking antibodies completely prevented Treg generation by both CD103 + and CD103 − DCs ( Figure 1A ). FoxP3 induction was also significantly impaired when DCs and T cells were cultured in serum free medium ( Figure 1B-C) , despite comparable T cell proliferation to that seen in serum-replete medium (data not shown), indicating that the majority of TGF-β responsible for Treg generation was derived from serum in the culture medium, rather than endogenous production by DCs or T cells. However, it is worth noting that even in serum-free conditions, CD103 + DCs from control mice produced more Tregs than CD103 − DCs ( Figure  1C ).
Based on these data, we reasoned that CD103 + DCs may be better able to utilize exogenous TGF-β to promote FoxP3 expression in T cells. TGF-β is synthesized as an inactive 'latent' precursor which must be dissociated from binding proteins before it can engage TGF-β receptors, a process known as TGF-β activation. When MLN DCs were cultured with purified latent TGF-β, CD103 + DCs again induced significantly more FoxP3 + Tregs than CD103 − cells ( Figure 1B-C) . These data suggested to us that the difference in Treg generation between CD103 + and CD103 − DCs might be explained in part by a differential ability to activate latent TGF-β.
The preferential generation of Tregs by CD103 + Dcs has previously been linked to expression of high levels of aldh1a2 which confers on this DC subset the ability to synthesize and secrete RA, which promotes Treg generation 10, 11 . Consistent with these studies, CD103 + and CD103 − DCs produced equivalent proportions of FoxP3 + Tregs when cultured with active TGF-β and RA ( Figure 1D ). However, addition of RA was not sufficient to allow CD103 − DCs to efficiently generate Tregs in response to latent TGF-β. Therefore, the increased induction of FoxP3 + Tregs by CD103 + DCs was in part due to increased activation of latent TGF-β, independent of their ability to produce RA.
Intestinal CD103 + DCs activate TGF-β via αv integrins αv integrins are important physiological activators of latent TGF-β and mice deficient in both αvβ6 and αvβ8, or lacking the integrin binding site in the latency-associated peptide (LAP), develop phenotypes closely resembling TGF-β knockouts 12, 13 . We have previously reported that mice lacking αv integrins in myeloid cells have reduced numbers of intestinal Tregs and develop spontaneous colitis, and that DCs from the MLN of αv-deficient mice are impaired in their ability to induce Tregs in culture 14 . To determine whether this was due to specific defects in CD103 + DCs, CD103 + and CD103 − DCs were sorted from the MLN of αv-tie2 and control mice and cultured with naïve FoxP3-GFP T cells. CD103 + DCs from αv-knockout mice did not exhibit the enhanced generation of Tregs seen in CD103 + DCs from control mice, and instead induced similar numbers of Tregs to CD103 − DCs (Figure 2A-B) . We then tested the ability of αv-deficient DCs to activate TGF-β. In the presence of latent TGF-β, αv-deficient CD103 + DCs did not generate as many Tregs as CD103 + DCs from wild-type mice, and only produced similar proportions to CD103 − DCs, as we had seen in cultures with serum ( Figure 2C ). In contrast, active TGF-β stimulated Treg generation by αv-deficient CD103 + DCs to levels close to those seen in control CD103 + DCs ( Figure 2D ). The small difference in Treg generation between CD103 + DCs from control and αv-deficient cells in the presence of active TGF-β could be rescued by addition of RA ( Figure 2E ) suggesting that αv-deficient DCs may have a slightly reduced ability to generate RA.
However, the ability of αv-deficient CD103+ DCs to generate Tregs in the presence of latent TGF-β was not rescued by the addition of RA ( Figure 2E ). These data therefore indicate that MLN CD103 + DCs require αv integrins to activate latent TGF-β and generate Tregs. We interpret the small induction of FoxP3 + Tregs by CD103 − DCs or αv-deficient cells in cultures with latent TGF-β as a result of a small amount of contaminating active TGF-β in the latent TGF-β preparation, although it is possible that this results from activation of latent TGF-β by an αv-independent mechanism.
As MLN CD103 + DCs originate in the intestinal lamina propria, we tested whether all intestinal DCs exhibited a similar ability to activate TGF-β, or whether this was similarly restricted to CD103 + DCs. Consistent with a specialized function for CD103 + Dcs in both intestine and MLN, CD103 + DCs from both small intestine and colon induced more Tregs than CD103 − DCs in the presence of latent TGF-β ( Figure 3 ). Furthermore, as for MLN DCs, this was dependent on expression of αv integrins, and αv-deficient DCs from the intestine induced similar numbers of FoxP3 + Tregs to CD103 − DCs from either αv-knockout or control mice ( Figure 3 ). Together these data show that the preferential ability of intestinal CD103 + DCs to promote Treg generation in vitro is dependent on expression of αv integrins and appears to be due to an increased activation of latent TGF-β.
αv is required for intestinal conversion of peripheral T cells to FoxP3 + Tregs
CD103 + DCs are thought to be responsible for the generation of gut-homing Tregs from naïve T cells in vivo. 10, 11 . αv-conditional knockout mice have fewer intestinal FoxP3 + Tregs than control littermates, and develop spontaneous colitis 14 . We have hypothesized that this is due to failure of peripheral conversion of CD4 + T cells specific for intestinal antigens to FoxP3 + Tregs (so-called induced Tregs [iTregs]), which are required to regulate intestinal immunity.. In contrast, Tregs in lymphoid organs, which probably represent primarily 'natural Tregs' of thymic origin are unaffected by αv deficiency 14 . Consistent with this hypothesis, we recently showed that naïve CD4 + T cells adoptively transferred into αv-deficient lymphopenic SCID recipients do not differentiate into intestinal FoxP3 + Tregs, unlike T cells transferred into αv-expressing SCID mice 15 .
To test directly for the requirement for αv integrins in iTreg generation, we used a model of oral antigen-dependent Treg conversion 8, 10, 11 . αv-tie2 14 and littermate control mice were adoptively transferred with T cells from DO11.10 mice that express a transgenic TCR specific for ovalbumin. Recipients were then fed ovalbumin dissolved in drinking water for five consecutive days. After oral ovalbumin administration, DO11.10 + T cells were readily detected in small intestine and colon lamina propria, as well as the MLN and PP, of control recipients. A significant proportion of these cells expressed FoxP3 (between 10 and 40% depending on tissue examined; Figure 4 and data not shown), representing Tregs that had converted from naïve T cells in the intestinal environment in response to oral antigen 8, 10, 11 . In contrast, very few converted FoxP3 + DO11.10 cells were found in the intestine and intestinal lymph organs of αv-tie2 recipients (less than 8% in all tissues; Figure  4 ). As reported in other studies, almost no FoxP3 + DO11.10 cells were recovered from the intestine or lymph nodes of mice that did not receive ovalbumin, regardless of their genotype (data not shown). Thus, the induction of FoxP3 + Tregs in response to oral antigen was substantially impaired in αv-knockout mice.
αvβ8 integrin is preferentially expressed on DCs from mucosal tissues
The data presented above suggested that the preferential ability of MLN CD103 + DCs to generate Tregs in vitro and in vivo was due to their ability to activate TGF-β via αv integrins. αv associates with 5 different β subunits, β1, β3, β5, β6 and β8, and all have been shown to bind and activate TGF-β, albeit through different mechanisms and in different cell types 16 . To identify the specific αv integrin responsible for the preferential activation of TGF-β, we analyzed the expression of αv and pairing β integrins in DCs. We first compared integrin expression by MLN DCs with DCs from the spleen, by RT-PCR. αv, β3 and β5 integrins (encoded by genes Itgav, Itgb3 and Itgb5 respectively) were all expressed at equivalent levels in spleen and MLN DCs and β6 could not be detected in any DCs ( Figure  5A ). Strikingly, expression of β8 (Itgb8) was only detected in MLN DCs but not in spleen DCs. This was confirmed using QRT-PCR, which is significantly more sensitive than rt-PCR ( Figure 5C ). To determine whether these differences in gene expression led to changes in protein, we measured expression of β8 protein by western blot (suitable antibodies against mouse αvβ8 are not available for FACs). β8 could be readily detected in DCs from the MLNs but not spleen ( Figure 5D ) confirming that changes in β8 gene expression correlate with β8 protein levels.
We then tested whether β8 was differentially expressed between MLN DC subpopulations. CD11c + DCs from the MLNs were sorted by FACs based on CD103 and CD8α expression, and β8 expression measured ( Figure 5A-C) . The vast majority of β8 expression seen in MLN DCs was from the CD103 + subset and little or no expression could be seen by RT-PCR in CD8α + or CD8α/CD103 double negative cells (the majority of which correspond to CD11b + DCs). This was confirmed by QRT-PCR analysis, which indicated at least 10-fold higher levels β8 in CD103 + DCs compared with other MLN DCs.
Finally, we analysed αv and β integrin expression in DC subsets from peripheral lymph nodes, such as those that drain the skin, to determine whether β8 expression was limited solely to DCs derived from the intestine. We found that β8 was also selectively expressed by the CD103 + subpopulation of DCs from peripheral lymph nodes ( Figure 5E ), indicating a potential common role in generating Treg cells for CD103 + DCs in peripheral lymph nodes. However, it should be noted that expression was considerably lower than seen in MLN CD103 + DCs. Indeed, it is interesting that DCs could be readily clustered into the CD103 + , CD8α + and DN subsets based solely on relative expression of αv and pairing β integrins, the only exception being CD103 + DCs from the spleen. β8 could not be detected by QRT-PCR of RNA in this small population of cells and they instead clustered with CD8α + DCs in our analysis.
Analysis of expression of αv integrins therefore indicated that the preferential ability of CD103 + DCs to activate TGF-β and generate Tregs is most likely due to expression of αvβ8, which is present at much higher levels on this DC subset in the intestinal lymph nodes. This is in agreement with studies of β8 integrin conditional knockout mice, which have a similar phenotype to αv knockouts, developing colitis associated with loss of intestinal Tregs. Hence β8 appears to be the critical partner for αv in activation of TGF-β by DCs, conferring the preferential ability of CD103 + DCs to generate Tregs in the presence of latent TGF-β.
Discussion
A specific population of intestinal DCs, marked by expression of CD103, are emerging as important regulators of intestinal immunity through their ability to promote conversion of naïve T cells to FoxP3 + regulatory T cells that home to the intestine. Here we present data showing that the increased ability of CD103 + DCs to generate Tregs both in vitro and in vivo is completely dependent on the expression of αv integrins. This is due to an increased ability of CD103 + DCs to activate latent TGF-β, and CD103 + DCs are uniquely specialized for this role through expression of high levels of αvβ8, which is restricted to this lineage of cells.
These data build on our previous work 14 in which we demonstrated that deletion of αv from immune cells caused spontaneous colitis in mice. This was associated with a reduction in the numbers of FoxP3 + Tregs in the intestine, but not in lymph nodes or spleen, which we postulated was due to the selective loss of iTregs 14, 17 . Critically, this was caused by the deletion of αv, or the pairing β8 subunit 18 , from DCs, suggesting that αvβ8 was essential for DCs to generate intestinal iTregs. Here we demonstrate that this is the case and identify CD103 + DCs as the αvβ8 expressing DCs responsible. We therefore propose a model in which activation of latent TGF-β is tightly controlled by DCs, which 'license' TGF-β signaling to interacting naïve T cells in an antigen-dependent manner. This is supported by our recent work showing that T cell responses to latent TGF-β requires cognate interaction with αv-expressing DCs 15 . This mechanism appears to be of particular importance in tissues such as the intestine which are rich in latent TGF-β, and allows DCs to regulate TGF-b signaling to DCs regardless of the source of TGF-β. We have not directly addressed the source of TGF-β in this study, relying on exogenous addition of latent or active forms. However, it is likely T cells represent a major source in vivo as deletion of Tgfb1 in T cells alone led to a phenotype similar to that seen in DC-specific αv and β8 knockouts 19 .
We have recently reported that a similar αv-mediated mechanism regulates the differentiation of Th17 cells, which share a common precursor and a requirement for TGF-β early in development 15 . In that study, we did not identify the population of DCs required for TGF-β activation in Th17 responses, although they almost certainly express β8 as similar defects in Th17 cell generation were reported for DC-specific β8 knockout mice 20 . Supportive of this, DCs associated with Th17 cell induction in response to commensal bacteria have also been shown to upregulate itgav and itgb8 expression 21 . Upregulation of β8 in DCs is therefore a prerequisite for generation of TGF-β dependent T cell responses. It was striking to us that β8 expression was highly restricted to intestinal CD103 + DCs but was not seen in CD103 + DCs from the spleen, suggesting that β8 expression may be stimulated in response to signals encountered in the intestinal microenvironment. These may be derived from intestinal epithelial cells, which promote the ability of DCs to generate Tregs 22 , or from commensal bacteria 21 . Similar signals in skin, lung and other mucosal sites may also promote the expression of β8 ( Figure 5 ), and our observation that αv-tie2 mice develop inflammation in multiple tissues, including the lung and respiratory tract, show that similar regulatory mechanisms are likely to exist throughout the body 14 .
RA has also been implicated in the preferential generation of intestinal iTregs by CD103 + DCs 10, 11 . In addition to stimulating expression of gut homing receptors α4β7 integrin and CCR6 23, 24 , RA enhances Treg generation through promotion and stabilization of FoxP3 expression. Our data indicate that αvβ8 and RA have complementary roles in Treg generation. Hence, DC αv integrins are essential for generation of both iTreg and Th17 cells 14, 15 by mediating activation of TGF-β whereas RA acts downstream of αv to promote TGF-β-driven Treg generation by stabilization of FoxP3 expression and reciprocal inhibition of Th17 differentiation 25, 26 . RA may therefore play a more important role in maintaining the appropriate balance between Treg and Th17 cells, than in initiating regulatory T cell responses.
Taken together our data support a model in which intestinal CD103 + DCs are specialized for their role in inducing immune tolerance to oral antigens and the commensal microbiota through expression of αvβ8 integrin. These cells are uniquely placed to utilize the high levels of latent TGF-β present in the intestine to promote immunoregulatory T cell responses in interacting T cells. Hence, Treg induction is restricted by availability of TGF-β, by the lineage of the DC encountered and by the antigen specificity of the T cell. Our findings highlight the critical role of CD103 + DCs in inducing and maintaining intestinal tolerance and identify modulation of αvβ8 expression or function as a potential therapeutic target in inflammatory bowel disease.
Materials and Methods
Mice αv-tie2 mice 14, 15 backcrossed to BALB/c or C57BL/6 backgrounds (10 generations) were used. FoxP3 eGFP reporter mice were obtained from Vijay Kuchroo (Brigham and Women's Hospital, Boston, MA) 8 and DO11.10 mice from Jackson Labs (Bar Harbor, ME). All animals were housed under specific pathogen free conditions at Massachusetts General Hospital. Animal experiments were performed under appropriate licenses within local and national guidelines for animal care.
In vitro Treg generation assay
CD4 + T cells were sorted by magnetic separation (CD4 + pre-enrichment kit, Stem Cell Technologies) from splenocytes of FoxP3-GFP mice. Naïve CD4 + CD62L hi FoxP3-GFP − T cells were further sorted by FACs. For MLN DCs, MLNs were digested in RPMI1640 containing DNaseI (20 mg/ml) and Liberase TL (0.33 mg/ml; both from Roche) followed by incubation in PBS/2% BSA/10 mM EDTA. Filtered cell suspensions were enriched for DCs using an Optiprep gradient (SIGMA) and CD11c + CD103 + and CD103 − DCs further sorted by FACS. To prepare intestinal DCs, mice were first injected subcutaneously with B16 cells secreting Flt3-L 27 to increase yield of DCs. Lamina propria cells were prepared as described previously 15 and DCs enriched and FACS sorted as for MLN DCs. Naïve spleen T cells and MLN DCs were co-cultured in either RPMI 1640 medium supplemented with 10 % fetal bovine serum and 10 mM HEPES, or in serum free X-VIVO 15 medium (LONZA). Both media also contained 2 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin and 50 μM 2-β-mercaptoethanol. Cells were cultured in 500 μl volume containing 1-2 × 10 4 DCs and 2.5-5 × 10 4 naïve CD4 + T cells (1:5 DC:T cell ratio), in the presence of 0.5 μg/ml anti-CD3 antibody (145-2C11; BD Biosciences). Additional cytokines used were recombinant active-TGF-β1 (0.5 ng/ml) and purified human latent TGF-β (2 ng/ml; both from R&D Systems). Where stated cells were cultured in presence of 40 μg/ml blocking anti-TGF-β1, 2, 3 antibody (1D11; R&D Systems) or all-trans retinoic acid (100 nM; SIGMA). Cells were cultured for 4-5 days before analysis of Treg generation assessed by GFP expression.
In vivo Treg generation
CD4 + T cells were sorted from the spleen and peripheral lymph nodes of DO11.10 Tg mice by depletion (Miltenyi Biotech) and adoptively transferred into BALB/c-background αv-tie2 mice or littermate controls. Each mouse received 10 6 cells. Recipients were maintained on either normal drinking water, or a 1.5 % solution of ovalbumin (grade V; Sigma-Aldrich) for 5 days. On day 6, lymphocytes were isolated from MLNs, Peyer's patches and intestinal lamina propria of recipients 15 and FoxP3 expression in transferred cells assessed by FACS.
αv integrin expression analysis
DCs from spleen, MLN and intestine as described above. PLN and Peyer's patch DCs cells were prepared as for MLN. DCs were then sorted by FACS based on CD11c, CD103 and CD8α directly into TRIZOL LS (SIGMA) for RNA extraction. cDNA was synthesized using High Capacity Reverse Transcription kit (ABiosystem) and RT-PCR was performed with Taq DNA polymerase kit (TaKaRa) and analyzed on 1.4 % agarose gel. For real-time PCR analysis, αv and pairing β integrins levels were quantified using Eppendorf real-time PCR system according to manufacturer's instructions in SYBR green master mix (Applied Biosystems). Expression was normalized to the housekeeping gene β-actin.
Western blotting
DCs were sorted (>95%) from spleen and MLN leukocytes using CD11c microbeads (Miltenyi Biotech) and lysed in RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 % NP-40, 0.5 % Sodium deoxycholate, 0.1 % SDS, 5 mM EDTA) containing Complete protease inhibitor cocktail (Roche). Lysates were separated by MOPS-12 % PAGE, transferred to PVDF membrane and immunoblotted with antibodies against β8 integrin 28 and β-actin (AC-74; SIGMA).
Antibodies
The following antibodies were used: anti-CD11c-APC ( based on integrin gene expression (determined by QRT-PCR analysis, using mean expression from at least two independent cell and RNA preparations per DC subset). DCs cluster into three principal groups discriminated by expression of β8 and β3 integrins.
